FDA green-lights Infinitt cardiac display, analysis package

Lisa Fratt | | Health Imaging | Screening
Infinitt's Xelis Cardiac, a 2D, 3D and 4D display and analysis tool for coronary CT angiography and left ventricle analysis, has received clearance from the FDA.

Xelis Cardiac can be used as an integrated system with Infinitt's web-based PACS or as a stand-alone system, allowing any third-party PACS user to query, view and analyze DICOM studies.

The package includes three diagnostic modules: vessel analysis, functional ventricle analysis and calcium scoring.

Infinitt, the Phillipsburg, N.J.-based developer of image and information management systems for healthcare, added that the Xelis Calcium Scoring system is currently under FDA review.

 

 


Lisa Fratt

Related Content

Routine abdominal CTs offer insight into cardiovascular risk
Screening efforts have helped avert millions of cancer-related deaths in recent decades
What breast density status can tell us about cardiovascular risk
FDA clears AI tool that flags signs of heart disease in chest CT scans
Patients without PCPs struggle to access lung cancer screening, despite eligibility
Breast cancer rates among women in their 30s are on the rise

Around the web

Cardiovascular Business
New AI program delivers rapid, accurate echo video assessments

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Radiology Business
Key Medicare reimbursement and No Surprises Act updates from RSNA 2024

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.
 

Cardiovascular Business
Philips, Mayo Clinic using AI to improve cardiac MRI technology

The two companies aim to improve patient access to high-quality MRI scans by combining their artificial intelligence capabilities.